Phosphoinositide 3-kinases (PI3K) are known to regulate Toll-like receptor (TLR)-mediated inflammatory responses, but their impact on the different pathways of TLR signaling remains to be clarified. Here, we investigated the consequences of pharmacological inhibition of PI3K on Toll-IL-1 receptor domain-containing adapterinducing IFN-b (TRIF)-dependent signaling, which induces IFN-b gene expression downstream of TLR3 and TLR4. First, treatment of monocyte-derived dendritic cells (DC) with wortmannin or LY294002 was found to enhance IFN-b expression upon TLR3 or TLR4 engagement. In the same models of DC activation, PI3K inhibition increased DNA-binding activity of NF-jB, but not interferon response factor (IRF)-3, the key transcription factors required for TLR-mediated IFN-b synthesis. In parallel, wortmannin-treated DC exhibited enhanced levels of IjB kinase (IKK)-a/b phosphorylation and IjB-a degradation with a concomitant increase in NF-jB nuclear translocation. Experiments carried out in HEK 293T cells stably expressing TLR3 or TLR4 confirmed that inhibition of PI3K activity enhances NF-jB-dependent promoters as well as IFN-b promoter activities without interfering with transcription at the positive regulatory domain III-I. Furthermore, wortmannin enhanced NF-jB activity induced by TRIF overexpression in HEK 293T cells, while overexpression of catalytically active PI3K selectively attenuated TRIF-mediated NF-jB transcriptional activity. Finally, in coimmunoprecipitation experiments, we showed that PI3K physically interacted with TRIF. We conclude that inhibition of PI3K activity enhances TRIF-dependent NF-jB activity, and thereby increases IFN-b synthesis elicited by TLR3 or TLR4 ligands.